Sumatriptan Galpharm (sumatriptan)
Generic
- Region
- 🇪🇺 EU
- Active substance
- sumatriptan
- Company
- Galpharm Healthcare Ltd.
- Status
- Refused
- Therapeutic area
- Migraine Disorders
- CHMP opinion
- Thu 17 Nov 2011
- Designations
- Generic
- Application
- EMEA/H/C/002140
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Follow Sumatriptan Galpharm
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.